Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Karp

Showing results (181-190 of 214) with videos related to

Pageof 22
Sort By:
Plos Medicine|September 26, 2008
Ethical and practical issues associated with aggregating databasesDavid R Karp, Shelley Carlin, Robert Cook-Deegan, et al.
Circulation Research|November 5, 2005
FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthaseChieko Mineo, Andrew K Gormley, Ivan S Yuhanna, et al.
Frontiers in Immunology|June 20, 2022
Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated IndividualsMelissa E Munroe, Kendra A Young, Joel M Guthridge, et al.
Lupus|January 23, 2014
Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controlsK A Young, D R Terrell, J M Guthridge, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2020
American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1Dawn M Wahezi, Mindy S Lo, Tamar B Rubinstein, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 11, 2021
American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 2Dawn M Wahezi, Mindy S Lo, Tamar B Rubinstein, et al.
JAMA Network Open|April 4, 2023
Prevalence of Antiphospholipid Antibodies and Association With Incident Cardiovascular EventsYu Zuo, Sherwin Navaz, Wenying Liang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 16, 2025
A Randomized, Placebo-Controlled Trial of Hydroxychloroquine in Incomplete LupusNancy J Olsen, Duanping Liao, Judith A James, et al.
Annals of the Rheumatic Diseases|August 28, 2007
Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosusA H Sawalha, K M Kaufman, J A Kelly, et al.
Lupus Science & Medicine|April 15, 2017
Use of SLICC criteria in a large, diverse lupus registry enables SLE classification of a subset of ACR-designated subjects with incomplete lupusTeresa Aberle, Rebecka L Bourn, Hua Chen, et al.
Pageof 22

Showing results (181-190 of 214) with videos related to

Sort By:
Pageof 22
Plos Medicine|September 26, 2008
Ethical and practical issues associated with aggregating databasesDavid R Karp, Shelley Carlin, Robert Cook-Deegan, et al.
Circulation Research|November 5, 2005
FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthaseChieko Mineo, Andrew K Gormley, Ivan S Yuhanna, et al.
Frontiers in Immunology|June 20, 2022
Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated IndividualsMelissa E Munroe, Kendra A Young, Joel M Guthridge, et al.
Lupus|January 23, 2014
Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controlsK A Young, D R Terrell, J M Guthridge, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2020
American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1Dawn M Wahezi, Mindy S Lo, Tamar B Rubinstein, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 11, 2021
American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 2Dawn M Wahezi, Mindy S Lo, Tamar B Rubinstein, et al.
JAMA Network Open|April 4, 2023
Prevalence of Antiphospholipid Antibodies and Association With Incident Cardiovascular EventsYu Zuo, Sherwin Navaz, Wenying Liang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 16, 2025
A Randomized, Placebo-Controlled Trial of Hydroxychloroquine in Incomplete LupusNancy J Olsen, Duanping Liao, Judith A James, et al.
Annals of the Rheumatic Diseases|August 28, 2007
Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosusA H Sawalha, K M Kaufman, J A Kelly, et al.
Lupus Science & Medicine|April 15, 2017
Use of SLICC criteria in a large, diverse lupus registry enables SLE classification of a subset of ACR-designated subjects with incomplete lupusTeresa Aberle, Rebecka L Bourn, Hua Chen, et al.
Pageof 22